Live feed07:00:00·42mPRReleasevia QuantisnowAdlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADCByQuantisnow·Wall Street's wire, on your screen.ANL· Adlai Nortye Ltd.Health Care
